SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Biotech Jim
Robohogs
To: JamesK who wrote (7393)2/19/2019 9:54:09 AM
From: tuck2 Recommendations  Read Replies (1) of 7424
 
Shorting the ICPT news. It's going to be a tough launch in that market with the pruritus issue. Am also hearing they danced around a Hy's law question :>|

Edit: to elaborate on pruritus, the dropout rate due to that was 9% in the 25mg arm, the one that demonstrated efficacy. Severe pruritus mandated discontinuation. So the vast majority of the pruritus related dropouts were at patient discretion. That's not going to help sales.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News